the freedom-meditech clearpath ds 120

2
The CLEARPATH DS-120™ is cleared by FDA as a tool for the measurement of autofluorescence by scanning the crystalline lens of the eye with a blue light. In independent scientific studies published in peer-reviewed journals, elevated autofluorescence measurements have been linked to high levels of advanced glycosylated end products which accumulate in the presence of diabetes. Breakthrough in Non-Invasive Lens Autofluorescence Detection Fluorescence vs. Age Prediction Ratio Chart Fluorescence Ratio Age Observed fluorescence ratios from healthy eyes of 127 healthy subjects, with no cataracts, from Freedom Meditech clinical study. NEW PRODUCT LAUNCH! @FreedomMeditech Follow Us MKT-005REVA

Upload: eyefficient

Post on 24-Jun-2015

104 views

Category:

Documents


3 download

TRANSCRIPT

Page 1: The Freedom-Meditech Clearpath ds 120

The CLEARPATH DS-120™ is cleared by FDA as a tool for the measurement of autofluorescence by scanning the crystalline lens of the eye with a blue light.

In independent scientific studies published in peer-reviewed journals, elevated autofluorescence measurements have been linked to high levels of advanced glycosylated end products which accumulate in the presence of diabetes.

Breakthrough in Non-Invasive Lens Autofluorescence Detection

Fluorescence vs. Age Prediction Ratio Chart

Fluo

resc

ence

Rat

io

Age

Observed fluorescence ratios from healthy eyes of 127 healthy subjects, with no cataracts, from Freedom Meditech clinical study.

NEW PRODUCT LAUNCH!

@FreedomMeditech

Follow Us

MKT-005REVA

Page 2: The Freedom-Meditech Clearpath ds 120

NEW PRODUCT LAUNCH!

@FreedomMeditech

Follow Us

MKT-005REVA